Literature DB >> 22939347

The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.

Nattika Saengkrit1, Phakorn Sanitrum, Noppawan Woramongkolchai, Somsak Saesoo, Nuttaporn Pimpha, Saowaluk Chaleawlert-Umpon, Tewin Tencomnao, Satit Puttipipatkhachorn.   

Abstract

In this study, we examined the potential of cationic nanoparticle - polyethyleneimine-introduced chitosan shell/poly (methyl methacrylate) core nanoparticles (CS-PEI) for siRNA delivery. Initially, DNA delivery was performed to validate the capability of CS-PEI for gene delivery in the human cervical cancer cell line, SiHa. siRNA delivery were subsequently carried out to evaluate the silencing effect on targeted E6 and E7 oncogenes. Physicochemical properties including size, zeta potential and morphology of CS-PEI/DNA and CS-PEI/siRNA complexes, were analyzed. The surface charges and sizes of the complexes were observed at different N/P ratios. The hydrodynamic sizes of the CS-PEI/DNA and CS-PEI/siRNA were approximately 300-400 and 400-500nm, respectively. Complexes were positively charged depending on the amount of added CS-PEI. AFM images revealed the mono-dispersed and spherical shapes of the complexes. Gel retardation assay confirmed that CS-PEI nanoparticles completely formed complexes with DNA and siRNA at a N/P ratio of 1.6. For DNA transfection, CS-PEI provided the highest transfection result. Localization of siRNA delivered through CS-PEI was confirmed by differential interference contrast (DIC) confocal imaging. The silencing effect of siRNA specific to HPV 16 E6/E7 oncogene was examined at 18 and 24h post-transfection. The results demonstrated the capacity of CS-PEI to suppress the expression of HVP oncogenes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939347     DOI: 10.1016/j.carbpol.2012.06.079

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  5 in total

1.  An in silico approach to design potential siRNA molecules for ICP22 (US1) gene silencing of different strains of human herpes simplex 1.

Authors:  Suza Mohammad Nur; Mohammad Al Amin; Rashel Alam; Md Anayet Hasan; Md Amzad Hossain; Adnan Mannan
Journal:  J Young Pharm       Date:  2013-06-20

Review 2.  Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.

Authors:  Azam Bolhassani; Shabnam Javanzad; Tayebeh Saleh; Mehrdad Hashemi; Mohammad Reza Aghasadeghi; Seyed Mehdi Sadat
Journal:  Hum Vaccin Immunother       Date:  2013-10-15       Impact factor: 3.452

3.  Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection.

Authors:  Qin Qin; Yunjie Shi; Qingqing Zhao; Dan Luo; Yuan Chen; Jing Wu; Min Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-31       Impact factor: 3.117

Review 4.  The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.

Authors:  Janice García-Quiroz; Bismarck Vázquez-Almazán; Rocío García-Becerra; Lorenza Díaz; Euclides Avila
Journal:  Cells       Date:  2022-08-15       Impact factor: 7.666

Review 5.  Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.

Authors:  Mohamed Shehata Draz; Binbin Amanda Fang; Pengfei Zhang; Zhi Hu; Shenda Gu; Kevin C Weng; Joe W Gray; Fanqing Frank Chen
Journal:  Theranostics       Date:  2014-06-11       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.